Immune-evasive Omicron strains BQ1, BQ1.1 spreading fast
Immune evasive BQ! strains spreading fast in the US and European countries
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Immune evasive BQ! strains spreading fast in the US and European countries
Happiness can be achieved by responding to circumstances in a positive manner
FDA confirms Adderall shortage due to problems in Teva Pharma's supply pipeline
Study says overconsumption of ultra processed food leads to adverse mental health outcomes
Moderna’s mRNA vaccine is being studied in combination with Merck’s Keytruda to treat patients with high-risk melanoma
Neumora Therapeutics raises $650 million to date to revolutionize treatment of brain diseases
Liver cancer deaths set to increase by 50 percent by 2040; study
Evgen Pharma and Stalicla sign a $165 million licensing deal for neuro development disorder SFX-01 asset
Merck's Covid-19 pill no help in reducing hospitalization or death, Astrazenaca's nasal spray too fails trial
HQ team October 12, 2022: Marksans Pharma, a listed company, is set to acquire a manufacturing site of Tevapharm, an Indian subsidiary of.